News
22h
MedPage Today on MSNGLP-1 Med Users See Drop in Recurrent Afib EventsAccounting for mortality as competing risk, the Afib burden trended numerically in favor of the GLP-1 RA group (HR 0.85, 95% ...
Experts express alarm that GLP-1 RAs may trigger or worsen eating disorders. But is there any role they might play in binge ...
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
A woman who privately purchased an injectable GLP-1 weight-loss medication is claiming it made her hair fall out and gave her ...
Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.
Last week, Pfizer announced that it would no longer develop danuglipron, a daily GLP-1 weight-loss drug which investors were ...
Wellness influencer Janelle Rohner reveals she is 'microdosing' GLP-1 medication for weight loss and addresses criticism over ...
"You should have a minimum of three bowel movements per week, preferably one a day. A patient from the ER started vomiting ...
Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...
Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...
A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results